Lv2
174 积分 2024-07-10 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
1天前
待确认
Toward In Vivo CAR T Cell Therapy: Perfecting CAR and Lipid Nanoparticle Design
1天前
已完结
Abstract 1614: Novel anti-CD3 single domain antibodies for the development of T cell engager
23天前
已完结
Abstract 5406: A novel AI-engineered biparatopic DLL3/CD3 T cell engager demonstrates potent preclinical efficacy and a promising safety profile
23天前
已完结
Improved protein structure prediction using potentials from deep learning
24天前
已完结
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning
24天前
已完结
Structural basis of assembly of the human T cell receptor–CD3 complex
26天前
已完结
The impact of CD3 affinity-attenuation on T cell engaging bispecific antibodies: is it really that simple?
27天前
已完结
Geometric Antibody Engineering Reveals the Spatial Factor on the Efficacy of Bispecific T Cell Engagers
27天前
已完结
Design and characterization of novel peptide-coated lipid nanoparticles for targeting anti-HIV drug to CD4 expressing cells
27天前
已完结
皖公网安备34019202002308
